Considering these findings and the close association of NRP1 and lenvatinib with cell migration and angiogenesis in cancer [9, 29], we performed the next experiments in the Hep3B and Huh-7 cell lines to precisely evaluate the role of NRP1 in lenvatinib efficacy in HCC. The gene discussed is NRP1; the disease is hepatocellular carcinoma.